CStone Pharmaceuticals ('CStone,' HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, immunology, inflammation, and other key ...
Olverembatinib, an investigational multikinase inhibitor (approved in China for CML), inhibits Src-family kinases (e.g., Lyn, ...
Revolution Medicine has wowed investors and analysts by announcing dazzling data from its Phase III RASolute 302 trial ...
Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), a clinical-stage oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved antibody drug ...
Summary of Phase 1 Zoldonrasib Data at AACR 2026 ( Abstract # CT021 ) ...
Zai Lab Limited (NASDAQ:ZLAB) is one of the 10 Overlooked Growth Stocks to Buy Now. Zai Lab Limited (NASDAQ:ZLAB) is one of ...
Morning Overview on MSN
Study links household radon exposure to higher ovarian cancer risk
Radon already has a well-earned reputation as a lung cancer threat. Now a systematic review published in Frontiers in Public ...
The advent of mRNA vaccines against SARS-CoV-2 in 2020 changed the course of the COVID-19 pandemic. Now, the Nobel ...
Non-small cell lung cancer (NSCLC) remains a predominant cause of cancer-related mortality worldwide. In recent years, immune ...
The Drug Controller General of India (DCGI) has approved Keytruda for multiple cancer types. As of recent approvals, it ...
Lunit's AACR 2026 presentations showed how AI-driven biomarkers can improve the efficiency of clinical workflows, uncover ...
The results suggest the drug boasts similar safety and efficacy in non-small cell lung cancer compared with the field’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results